Candriam Equities L Biotechnology Class C USD DisRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/04/2024 |
|
Annual Returns (GBP) | 30/04/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/04 | |
Price Return | 15.66 | -5.74 | 29.71 | 15.52 | -1.79 | 10.88 | 1.09 | -1.91 |
+/- Category | 5.37 | 2.22 | 9.51 | -10.45 | 7.24 | 18.72 | 2.37 | 1.81 |
+/- Category Index | 0.47 | -3.89 | 13.00 | -17.42 | -2.09 | 8.42 | -6.24 | -8.35 |
% Rank in Category | 24 | 37 | 10 | 73 | 35 | 2 | 32 | 41 |
Trailing Returns (GBP) | 02/05/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 2.95 | 1.76 | 3.62 |
1 Week | 4.20 | -1.30 | 3.28 |
1 Month | -0.34 | 0.29 | -0.12 |
3 Months | -0.95 | -3.30 | -6.02 |
6 Months | 13.83 | -2.44 | -0.21 |
YTD | 1.22 | 0.77 | -5.67 |
1 Year | 6.62 | 1.71 | -6.23 |
3 Years Annualised | 5.01 | 9.52 | -2.19 |
5 Years Annualised | 9.17 | 2.59 | -2.88 |
10 Years Annualised | 11.47 | 1.85 | -0.20 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/04/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.72 | - | - | - |
2023 | -5.36 | -0.10 | -1.35 | 8.38 |
2022 | -4.00 | -0.06 | 13.43 | 1.90 |
2021 | -5.98 | 6.59 | 0.41 | -2.40 |
2020 | -5.34 | 24.99 | -5.88 | 3.73 |
2019 | 13.84 | 1.72 | -5.86 | 18.99 |
|
Advertisement |